This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsEyePoint PharmaceuticalsEyePoint Pharmaceuticals Funding Rounds, Valuation & Investors
EyePoint Pharmaceuticals
Develops sustained-release therapeutics for serious eye disorders51-200 EmployeesActively Hiring
EyePoint Pharmaceuticals Funding
$150M
11 round
EyePoint Pharmaceuticals is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $150M. Their most recent funding was raised on October 14, 2025.
Funding Rounds
S
$150000000